Diagnostic Procedure
Medtronic Advances Diabetes Management with FDA Clearance of InPen App and Launch of Smart MDI System
Medtronic, FDA clearance, InPen app, Smart MDI system, diabetes management, insulin therapy, continuous glucose monitoring (CGM), Simplera CGM
Roche Advances Alzheimer’s Disease Diagnosis with Breakthrough Blood Test
Alzheimer’s disease, blood test, Roche, Eli Lilly, FDA breakthrough device designation, pTau217, amyloid pathology, early diagnosis.
Novartis Secures First-Line Approval for Scemblix in Newly Diagnosed Chronic Myeloid Leukemia Patients
Scemblix, Novartis, first-line approval, chronic myeloid leukemia, CML, newly diagnosed, FDA approval
Siemens Healthineers Secures FDA Approval for Revolutionary 3D Mammography System with 5-Second Acquisition Time
Siemens Healthineers, FDA approval, 3D mammography, Mammomat B.brilliant, breast cancer screening, wide-angle technology, tomosynthesis, PlatinumTomo, UltraHD image reconstruction.
HPV-Based Cervical Cancer Screening: Insights into Sample Preference and Cost-Effectiveness
HPV testing, Cervical cancer screening, Sample preference, Cost-effectiveness, Screening guidelines
Novo Nordisk’s GLP-1 Agonist Demonstrates Significant BMI Reduction in Children Aged 6-12 in Phase 3 Trial
GLP-1 agonists, obesity, weight loss, liraglutide, semaglutide, pediatric obesity, BMI reduction, Novo Nordisk, Phase 3 trial.
SpectraWAVE Secures $50M Series B Funding Led by J&J to Enhance Intravascular Imaging System
SpectraWAVE, Johnson & Johnson, intravascular imaging, HyperVue Imaging System, coronary artery disease, medical imaging, Series B funding
Novartis Expands Radioligand Therapy Production with Two New US Facilities
Novartis, radioligand therapy, RLT, cancer treatment, manufacturing facilities, US expansion
EU High Court Rules in Favor of Illumina in Grail Acquisition Appeal
Illumina, Grail, European Court of Justice, Acquisition, Antitrust Litigation, Liquid Biopsy
WuXi AppTec Unfazed by BIOSECURE Act Threat, Secures New US Deals
WuXi AppTec, BIOSECURE Act, US Deals, Pharmaceutical Manufacturing, Biotech Industry